These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 36465369)

  • 1. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
    Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
    Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
    Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
    Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression.
    Liu Z; Li J; Chen J; Shan Q; Dai H; Xie H; Zhou L; Xu X; Zheng S
    BMC Cancer; 2018 Feb; 18(1):200. PubMed ID: 29463213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative Analysis of Minichromosome Maintenance Proteins and Their Prognostic Significance in Melanoma.
    Han W; Wu YZ; Zhao XY; Gong ZH; Shen GL
    Front Oncol; 2021; 11():715173. PubMed ID: 34490114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minichromosome Maintenance (MCM) Family as potential diagnostic and prognostic tumor markers for human gliomas.
    Hua C; Zhao G; Li Y; Bie L
    BMC Cancer; 2014 Jul; 14():526. PubMed ID: 25046975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma.
    Lv L; Zhang Y; Zhao Y; Wei Q; Zhao Y; Yi Q
    Front Cell Neurosci; 2021; 15():704344. PubMed ID: 34335194
    [No Abstract]   [Full Text] [Related]  

  • 9. The N6-Methylandenosine-Related Gene
    Jiang X; Shi Y; Chen X; Xu H; Huang X; Li L; Pu J
    Front Mol Biosci; 2022; 9():773662. PubMed ID: 35309512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and Prognostic Value of MCM Family Genes in Osteosarcoma.
    Zhou J; Wang M; Zhou Z; Wang W; Duan J; Wu G
    Front Mol Biosci; 2021; 8():668402. PubMed ID: 34239894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatic Analysis of the Expression and Clinical Significance of the DNA Replication Regulator MCM Complex in Bladder Cancer.
    Chen R; Hu B; Jiang M; Deng W; Zheng P; Fu B
    Int J Gen Med; 2022; 15():5465-5485. PubMed ID: 35698656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC10A3 Is a Prognostic Biomarker and Involved in Immune Infiltration and Programmed Cell Death in Lower Grade Glioma.
    Ma W; Mei P
    World Neurosurg; 2023 Oct; 178():e595-e640. PubMed ID: 37543196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
    Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
    BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of minichromosome maintenance mRNA expression in human lung adenocarcinoma.
    Li S; Jiang Z; Li Y; Xu Y
    Oncol Rep; 2019 Dec; 42(6):2279-2292. PubMed ID: 31545501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.
    Xu J; Liu F; Li Y; Shen L
    Cell Mol Neurobiol; 2022 Apr; 42(3):709-722. PubMed ID: 32894375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients.
    Liu F; Tu Z; Liu J; Long X; Xiao B; Fang H; Huang K; Zhu X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34988580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma.
    Lan H; Yuan J; Chen X; Liu C; Guo X; Wang X; Song J; Cao K; Xiao S
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34859821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
    Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
    Front Neurol; 2022; 13():977180. PubMed ID: 36353126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of minichromosome maintenance genes in renal cell carcinoma.
    Zhong H; Chen B; Neves H; Xing J; Ye Y; Lin Y; Zhuang G; Zhang SD; Huang J; Kwok HF
    Cancer Manag Res; 2017; 9():637-647. PubMed ID: 29180899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.